Your gateway to a free society
Article
Comcast Shares Jump Most Since 2008 On Plans To Separate Units
Comcast Shares Jump Most Since 2008 On Plans To Separate Units
Comcast shares jumped the most in nearly two decades on news that it plans to split NBCUniversal and Sky into a separate publicly traded company through a tax-free spin-off.
The transaction, expected to close in about one year, would leave Comcast shareholders owning stakes in both.
Comcast would remain centered around broadband, wireless, business services, and entertainment platforms, backed by a network that reaches more than 65 million homes and businesses.
NBCUniversal, which will also include Sky, will house Universal’s film...
aboutLiberty Portal
Liberty Portal is your gateway for free markets and free thinking. We aggregate open-sourced content to promote and popularize important people and lessons within the liberty movement.
suggested
Mar 13, 2026 / Tyler Durden
In Scramble To Open Up Hormuz, France & Italy Open Talks With Iran After India's Request
In Scramble To Open Up Hormuz, France & Italy Open Talks With Iran After India's Request
Amid very confused and mixed messaging coming from Washington over the status and future fate of Hormuz oil transit, the EU is trying its hand at a solution.
France and Italy have opened 'tentative' talks with Iran seeking to negotiate a deal to guarantee safe passage for their tankers through vital strait which remains a crucial chokepoint for stalled global crude transit, the Financial Times reports Friday, citing people briefed on the efforts.
This comes as...
Read more
Jun 27, 2026 / Tyler Durden
Apple Wants To Buy Memory From China As Soaring Chip Prices Spark Inflation Shock
May 6, 2026 / Tyler Durden
Novo Nordisk Soars After New Obesity Pill Momentum Lifts Guidance
Novo Nordisk Soars After New Obesity Pill Momentum Lifts Guidance
Novo Nordisk shares jumped as much as 9% in Copenhagen, suggesting the stock may finally be bottoming out after a vicious multi-year bear market. The move followed the Danish drugmaker's decision to raise its 2026 guidance ranges for adjusted sales and adjusted operating profit, citing solid momentum in Wegovy sales.
Novo now expects full-year sales and profit declines of around 12%, down from a previous forecast of around 13%. The upgraded outlook was "driven by increased expectations for GLP-1 product sales,"...
Read more
support
If you like what we do and want to support us, then you are a fine humanitarian. Click the link below to find out more.
Support the liberty movement
Want to get in touch?